RKL Wealth Management LLC Has $404,000 Stake in Henry Schein, Inc. (NASDAQ:HSIC)

RKL Wealth Management LLC reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 10.8% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 5,840 shares of the company’s stock after selling 704 shares during the period. RKL Wealth Management LLC’s holdings in Henry Schein were worth $404,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Farther Finance Advisors LLC raised its position in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of Henry Schein by 2.1% in the 3rd quarter. Principal Financial Group Inc. now owns 145,835 shares of the company’s stock worth $10,631,000 after acquiring an additional 3,037 shares in the last quarter. Covestor Ltd raised its holdings in shares of Henry Schein by 31.2% in the third quarter. Covestor Ltd now owns 1,987 shares of the company’s stock valued at $144,000 after purchasing an additional 473 shares during the last quarter. River Global Investors LLP raised its holdings in shares of Henry Schein by 12.3% in the third quarter. River Global Investors LLP now owns 140,386 shares of the company’s stock valued at $10,237,000 after purchasing an additional 15,336 shares during the last quarter. Finally, Entropy Technologies LP lifted its position in shares of Henry Schein by 29.3% during the third quarter. Entropy Technologies LP now owns 22,096 shares of the company’s stock valued at $1,611,000 after purchasing an additional 5,005 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on HSIC. Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. UBS Group decreased their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Trading Up 2.2 %

Shares of Henry Schein stock opened at $74.59 on Friday. The stock has a market capitalization of $9.26 billion, a P/E ratio of 30.70, a P/E/G ratio of 2.13 and a beta of 0.91. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock’s 50-day simple moving average is $74.48 and its 200 day simple moving average is $72.51.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the firm earned $0.66 EPS. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.